Status:
TERMINATED
Prediction and Maintenance of Sinus Rhythm Among Atrial Fibrillation Patients
Lead Sponsor:
Crystal Blake-Parlin
Collaborating Sponsors:
MaineHealth
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
Phase:
NA
Brief Summary
Atrial fibrillation (AF) is the most common heart rhythm disorder seen in clinical practice, with an estimated 2.7-6.1 million people in the U.S. affected by the disorder \[1\]. Previous studies have ...
Detailed Description
Atrial fibrillation (AF) is a heart rhythm disorder in which the normal beating in the upper chambers of the heart is irregular, leading to poor blood flow to the lower chambers. Risk factors include ...
Eligibility Criteria
Inclusion
- • Patients identified at PBMC with a documented diagnosis of AF (at any point in time) and who have undergone any cardioversion.
- The patient would also need to have had an echocardiogram within six months pre-cardioversion (performed for any reason) with a well visualized atrial roof in order to perform the measurements accurately using the TOMTEC-ARENA software.
Exclusion
- • Patients with a mitral regurgitation greater than moderate (effective regurgitant orifice \>= .2 mm2)
- Patients with post-surgical valve repair or replacement, if the procedure was done with a thoracotomy
- Any patient how has had any cardiac surgery requiring a thoracotomy
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 6 2022
Estimated Enrollment :
209 Patients enrolled
Trial Details
Trial ID
NCT04313296
Start Date
May 1 2020
End Date
September 6 2022
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pen Bay Medical Center
Rockport, Maine, United States, 04856